NCT03854734

Brief Summary

This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropriate vaccines, including human papillomavirus (HPV), meningitis (MCV) and tetanus, diphtheria, pertussis (TDap).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2019

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 26, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 12, 2024

Completed
Last Updated

July 12, 2024

Status Verified

January 1, 2024

Enrollment Period

1 year

First QC Date

February 20, 2019

Results QC Date

March 18, 2023

Last Update Submit

January 26, 2024

Conditions

Keywords

VaccinationsVaccine hesitancySchool-based research

Outcome Measures

Primary Outcomes (1)

  • Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)

    Parental intent to vaccinate their adolescent child with Tdap, MCV, and HPV vaccines, was dichotomized for each vaccine in the survey. Tdap and MCV included the options 1) intention to vaccinate/vaccinated ("plan to get this shot before the first day of 7th grade" or "up-to-date with this shot") or 2) no intention to vaccinate ("no plans to get this shot" or "have or plan to submit an exemption for this shot"). The HPV variable excluded the option "have or plan to submit an exemption for this shot" as vaccine is not required for school entry. Variables (Tdap, MCV, HPV) were compared within and between treatment groups from baseline to 6 mo. follow up with a generalized estimating equations model using the framework of a log-binomial logistic regression model. Risk ratios resulting from these models were used to quantify the magnitude and direction of any significant differences.

    Participants were assessed at baseline and follow-up at 6 months.

Study Arms (2)

Usual Care

NO INTERVENTION

Educational emails about broad health topics to keep control group engaged

Multi-Component Intervention

ACTIVE COMPARATOR

(1) a community event to raise parental awareness of the importance of vaccination; (2) social marketing to target parents' attitudes and knowledge around vaccinations in the form of educational material

Behavioral: Community EventBehavioral: Educational Material

Interventions

Community EventBEHAVIORAL

Formative focus group data was used to design an educational community event to improve information share and vaccine education/knowledge.

Multi-Component Intervention

Formative focus group data was used to design educational messaging to be electronically distributed to intervention participants

Multi-Component Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Parents and guardians of children who attend a School District of Lancaster middle schools
  • Individuals who read and understand English
  • Individuals with an email address

You may not qualify if:

  • Individuals who are non-English speaking
  • Parents/Guardians \<18 years or older who do not have children attending a middle school in the School District of Lancaster
  • Individuals who do not have an email address
  • Individuals who plan on moving out of the Lancaster City area in the next year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State College of Medicine

Hershey, Pennsylvania, 17033, United States

Location

Related Links

MeSH Terms

Conditions

Vaccination Hesitancy

Condition Hierarchy (Ancestors)

Vaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Limitations and Caveats

We experienced low parent participation in the intervention activities, potentially limiting the effectiveness of the intervention and resulting outcomes.

Results Point of Contact

Title
Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences
Organization
Penn State College of Medicine

Study Officials

  • Jennifer Kraschnewski

    Penn State College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Following collection of baseline data, schools will be randomized. Study staff measuring the primary outcome will be blinded to school group assignment. Given the intervention, it is not possible to blind participants to group assignment.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2019

First Posted

February 26, 2019

Study Start

February 14, 2019

Primary Completion

February 28, 2020

Study Completion

February 9, 2023

Last Updated

July 12, 2024

Results First Posted

July 12, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

The following steps will be taken to protect subjects' privacy interests: identification and recruitment of potential subjects follows procedures consistent with privacy standards; consent discussion and research interventions will take place in a private setting; the information being collected will be limited to only the minimum amount of data necessary to accomplish the research purposes; the people with access to the identifiable research data will be limited to the minimum necessary as specified in the application and consent process. To external researchers or sponsors, data will be sent sent/received in aggregate/metrics (just counts, no individual data).

Locations